XML 27 R61.htm IDEA: XBRL DOCUMENT v2.4.0.6
LEGAL PROCEEDINGS AND CONTINGENCIES (Details) (USD $)
In Millions, unless otherwise specified
1 Months Ended 9 Months Ended
Nov. 30, 2008
Plavix Intellectual Property Litigation [Member]
Sep. 30, 2012
Plavix Intellectual Property Litigation [Member]
Sep. 30, 2012
AWP Litigation [Member]
Sep. 30, 2010
AWP Litigation [Member]
Mar. 31, 2011
Qui Tam Litigation [Member]
Sep. 30, 2012
Plavix Product Liability Litiagtion [Member]
Sep. 30, 2012
Environmental Proceedings New Brunswick [Member]
Oct. 30, 2011
Environmental Proceedings New Brunswick [Member]
Sep. 30, 2012
Hormone Replacement Therapy Product Liability [Member]
Sep. 30, 2012
Cercla Matters [Member]
Sep. 30, 2012
Reglan Product Liability [Member]
Mar. 31, 2010
Atripla Intellectual Property Litigation [Member]
Jan. 31, 2010
Atripla Intellectual Property Litigation [Member]
Apr. 30, 2009
Atripla Intellectual Property Litigation [Member]
Aug. 31, 2010
Baraclude Intellectual Property Litigation [Member]
Nov. 30, 2010
Sprycel Intellectual Property Litigation [Member]
Sep. 30, 2010
Sprycel Intellectual Property Litigation [Member]
Sep. 30, 2012
Environmental Proceedings North Brunswick [Member]
Dec. 31, 2013
Byetta Product Liability Litigation [Member]
Sep. 30, 2012
Byetta Product Liability Litigation [Member]
Sep. 30, 2012
BMS-986094 Product Liability [Member]
Legal Proceedings And Contingencies [Line Items]                                          
Litigation Settlement Gross                                   $ 4      
Number of patent infringement lawsuits                       2       4          
Damages sought by third-party 60                                        
Number of patents owned                       6   15 1   4        
Number of patents challenged                       2 8 2              
Number of lawsuits     4       250 100 35                     100 5
Loss Contingency Estimate Of Possible Loss       28           71                      
Number of current plaintiffs           2,000         2,700                 555  
Number of plaintiffs settled                 400                     200  
Number of sales representatives         3                                
Interest percentage on damages sought by third party   1.00%                                      
Number Of Clinical Trial Patients                                         300
Number of Scheduled Trials                                     $ 2